GlassScriptPhysician profile
Jeffrey B King
NPI 1194901942
$4,665.82
in general payments reported to CMS, 2019-2025
12 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,041 · 2020: $163 · 2021: $202 · 2022: $49.13 · 2023: $186 · 2024: $24.81.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $211.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $210.70 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Vivus LLC | $3,709.87 | 2019 | |
| Abbvie INC. | $177.32 | 2019-2022 | |
| Olympus America INC. | $154.92 | 2019-2021 | |
| Erbe USA INC | $140.36 | 2019-2023 | Erbe Vio3 Apc3 |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $136.88 | 2020-2022 | |
| Regeneron Pharmaceuticals, INC. | $134.02 | 2023-2024 | Dupixent |
| Braintree Laboratories, INC. | $110.03 | 2019-2021 | |
| Gilead Sciences, INC. | $34.92 | 2019 | |
| Medtronic, INC. | $19.77 | 2021 | |
| Ethicon US, LLC | $18.88 | 2019 | |
| Nestle Healthcare Nutrition INC. | $16.76 | 2022 | |
| Alfasigma USA, INC. | $12.09 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jeffrey King listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.